Scott Kellogg Email and Phone Number
An accomplished Senior Innovation & Strategy Executive, I have over two-decades of history in building first-in-kind science products for the pharma, biotech, digital health, and medical device industries. I have succeeded in building medical technology businesses with specialties and patents in digital therapy, ultrasound surgical modalities, transdermal IVD, neurostimulation, and therapeutic drug-device combinations. An inventor and engineer at heart, I have delivered results in fast-paced R&D, product development, drug delivery, regulatory strategy, clinical operations, GMP and IP environments.I have broad clinical experience across IBD/UC, ADHD, ASD, MS, PD, MDD, AD, TBI, Stroke, Diabetes, and Surgery.I am currently a member of the board of directors and former CEO of Suono Bio, which aims to be the pre-eminent biotech enabling oral delivery of biologics and genetic medicines. Leveraging technology from the laboratories of Professors Robert Langer and Giovanni Traverso (MIT), Suono Bio has demonstrated formulation-independent delivery of proteins and nucleic acids through the gastrointestinal tract. Previously I served as SVP in charge of medical devices (regulatory/clinical ops/quality) at Akili Interactive Labs, Inc. where we developed the first therapeutic mobile apps that can remotely download software directly to provide neuro-stimulation in a closed-loop and adaptive manner through an engaging video gaming experience. I led the design and execution of Akili's clinical trials, the successful submission and FDA clearance of Akili's de novo application for a pediatric ADHD treatment, and the CE certification. Before joining Akili, I was an integral member of the founding teams at Follica Bio, Afferent, Corp., Sontra Medical, Inc., and UltraCision, Inc. (now J&J), serving as VP of Business Operations, VP of Product Development, VP of R&D, and Director of Engineering. Additionally, I served in engineering leadership roles at Mentor Medical, Inc. (now J&J) and Ethicon Endo-Surgery, Inc. (J&J). I graduated with high honors from the University of Massachusetts at Amherst with a BS in engineering and received my MS and MBA from Northeastern University. I have specific technical expertise in therapeutic ultrasound and am an inventor on many domestic and international patents and lead inventor on key patents for the Harmonic Scalpel ($1B+/year product). In 2004, my team and I were awarded Popular Science’s “Best of What’s New in Healthcare.”See PATENTS HERE - http://bit.ly/483yasY
Suono Bio
View- Website:
- suonobio.com
- Employees:
- 4
-
Co-FounderGem-Biosciences, Inc. Aug 2024 - PresentMassachusettsCo-founded by Bob Langer and Gio Traverso at MIT, GEM-Biosciences promises to revolutionize wound care, inflammation, and regeneration treatments with its breakthrough Gas Entrapped Materials (GEM) technology, designed to administer therapeutic gases directly, safely, and effectively to the affected areas. Our first product promises to be a game-changing treatment for diabetic ulcers.
-
Member Bod / Chief Executive OfficerSuono Bio Nov 2020 - PresentFoxborough, Massachusetts, United StatesRecruited to lead vision, strategy, growth, and development of start-up biotech that enables first-generation products providing oral delivery of biologics and genetics, which is transformative to treating intractable diseases. Guiding investor outreach, P&L, BD outreach, partnerships, and piloting overall business execution to exceed goals. The product development leverages technology from the laboratories of Professors Robert Langer, Giovanni Traverso (MIT).• Successfully hit every milestone since starting the company, from product development, sourcing drugs, preclinical work and human trials in Australia, taking drugs from development to human trials in two years• Overseeing seven executives; recruited Head of Clinical Affairs, Head of Engineering, Head of Regulatory, and two junior engineers• Secured $8.5M in funding, tapping into a vast VC (Venture Capitalist) network, supporting the development of first-generation product and human trials within two years; negotiated license from MIT • Currently raising $15M for subsequent round funding
-
Svp Medical DevicesAkili Interactive Labs, Inc. Mar 2013 - Oct 2020Puretech Health - Boston MaRecruited to develop a company that launched a new industry with the world’s first therapeutic software algorithm as a mobile app to help children with ADHD. The first cleared indication was for the treatment of pediatric ADHD. The mobile apps use remotely downloaded software that directly provides neuro-stimulation in a closed-loop and adaptive manner through a video gaming experience. This proprietary technology was built on IP licensed from Dr. Adam Gazzaley's laboratory at UCSF. • Built infrastructure to develop software as a medical device, managed clinical operations, regulatory, and quality functions to ensure product success• Led design and execution of large randomized, controlled, blinded clinical trials, resulting in successful submission, FDA clearance of de novo application for pediatric ADHD; company received CE certification (June 2020)• Executed a regulatory strategy that brought FDA Pediatric Device Consortia, Ombudsman, and senior leadership to the table• Managed research collaborations with pharma partners: Shionogi Pharmaceuticals (Japan), Shire (early investors with first $500K in – now Takeda), and Pfizer research collaboration assessing tech for predicting amyloid status in pre-Alzheimer’s patients• Responsible for a $5M annual budget, leading nine parallel clinical programs with a 10-member team of quality, regulatory, and clinical operations leadership; grew the company from 3 to 80 associates, raising $120M in funding• Established the clinical KOLs (Key Opinion Leaders) – tapping top professors in ADHD from Duke and Mass General• Implemented process improvements to oversee nine clinical programs taking place at 30 sites across the US (Duke University / DCRI, UCSF, CHOP, Jewish National Hospital System, CNS Network) -
Vice President And Head Of Business OperationsFollica, Inc. Mar 2008 - Mar 2013Puretech Health - Boston MaRecruited to develop a company that created the first dermal de novo stem cell creation technology. Managed R&D, device development, clinical operations, IP, and regulatory functions. The in situ stem cell formation technology provided insights into stem cell formation to treat alopecia and debilitating scars. The technology is built on IP licensed from the laboratory of Dr. George Cotsarelis (Univ of Penn).• Managed $3M annual budget, responsible for 8-member team of scientists, drug developers, and engineers• Guided R&D, Clinical Operations, regulatory functions, managing the company’s lab, budgets, and portfolio• Led design and development of two human device trials and one drug-device combination OUS (Charité Hospital) trial; for the first time, these trials demonstrated the creation of neogenic hair follicles• Built functional teams and advisory boards, secured early funding, and managed the IP portfolio • Helped the company raise ~$17M and optimize devices and topical formulations invented to achieve continued and increased clinical results• Established infrastructure to formulate topical compounds, develop the skin perturbation device, and conduct preclinical screening - established the wet lab, dedicated vivarium, and medical device prototyping capability -
Vice President Of Product DevelopmentAfferent Corporation Sep 2006 - Mar 2008Providence, Rhode Island, United StatesConverted large cart-based laboratory devices into wearable devices with high-value disposal components. The company focused on developing a novel neuro-stimulation technology, which theorized it would accelerate neuroplasticity and aid in recovery from neurological trauma such as stroke. The technology was licensed from Dr. James Collins’ laboratory, formerly at Boston University.• Established the start-up team and drove redevelopment of a large-cart-based lab device footprint into a small, wearable device with a low-profile, piezo-based mechanical stimulator incorporated into a disposable electrode • Managed device development, quality management, and regulatory• Oversaw the external network of the product development team and Stryker Medical collaboration -
Vice President Of Research And DevelopmentSontra Medical Dec 1998 - Aug 2006Cambridge, Massachusetts, United StatesHired as a member of the start-up team; led the development of SonoPrep, a company that makes a handheld device that generates ultrasound acoustic cavitation to achieve enhanced skin permeability.• Led 12 direct reports composed of scientists and engineers, led the internal R&D team, and managed a $4M budget while expanding the IP portfolio. Sontra went public (2002), then merged with Echo Therapeutics (2007)• Successfully raised $11M before the IPO• Developed SonoPrep, a handheld device generating ultrasound acoustic cavitation to enhance skin permeability. This invention also included a novel feedback mechanism to control the dosage to achieve consistent permeability• Led development of SoniCate Transdermal Drug Delivery System, which the first commercial indication was for painless pediatric canulation• Led development of the Symphony Transdermal Continuous Glucose Monitoring System, including the proprietary highly sensitive sensor incorporated into a half-dollar-sized wearable transmitter (collaborated with Bayer Diagnostics, Abbott Laboratories -
Director Of R&D, Aesthetic InstrumentationMentor Medical (J&J) Jun 1997 - Oct 1998Norwell, Massachusetts, United StatesRebooted an extensive surgical program that had fallen behind schedule and was over budget. Steered a large multi-discipline team to develop the Contour Genesis system, an ultrasound generator, a handpiece with a surgical cannula, and incorporated suctions and irrigation devices. • Managed a $15M budget, responsible for the surgical device development functions• Directed a large internal 40-member team of electrical, software, mechanical, quality, and manufacturability engineers while supporting regulatory and clinical functions• Interfaced with world-renowned plastic surgeons to optimize and refine the design• Piloted team in completing the development of the Contour Genesis system in 14 months, setting a company record in vision to launch; the IDE clinical evaluation and clearance resulted in a highly successful commercial launch; personally recognized by the president of the company for truing the program in record time and on budget• Led successful transfer to manufacturing and redirected regulatory strategy away from PMA to 510(k), resulting in significant manufacturing and compliance savings• J&J subsequently acquired the company for $1.1B
-
Director Of EngineeringUltracision (J&J / Ethicon Endo-Surgery) Aug 1991 - May 1997Smithfield Ri / Cincinnati OhLeader in inventing and developing the Harmonic Scalpel, revolutionizing the emerging laparoscopic surgical field. The safety and efficacy profile of the technology-enabled multiple new procedures previously without a compelling surgical solution (laparoscopic cholecystectomy, Nissen fundoplication, and nephrectomy) and became a “gold standard” modality. Arrived during the early start-up stage as a junior engineer and ultimately led the electrical and software engineering teams that invented the control mechanisms for stable activation of long laparoscopic surgical waveguides. • Advanced capabilities of the surgical device development function, which today generates $1B+ annually• Developed the international technical service training and executed this program globally• Instrumental in the business integration after UltraCision was sold to J&J EES for $85M
Scott Kellogg Education Details
-
Business, Finance -
Accounting And Finance
-
Engineering
Frequently Asked Questions about Scott Kellogg
What company does Scott Kellogg work for?
Scott Kellogg works for Suono Bio
What is Scott Kellogg's role at the current company?
Scott Kellogg's current role is Chief Executive Officer | Drug Delivery | Digital Medicine | Medical Device.
What schools did Scott Kellogg attend?
Scott Kellogg attended Northeastern University, Northeastern University, University Of Massachusetts Amherst.
Who are Scott Kellogg's colleagues?
Scott Kellogg's colleagues are Bob Degon.
Not the Scott Kellogg you were looking for?
-
Scott Kellogg
Clearwater, Fl2tampabay.rr.com, jabil.com -
Scott Kellogg
Omaha Metropolitan Area2woodmen.org, gmail.com -
Scott Kellogg
United States2chemtura.com, lanxess.com3 +121544XXXXX
-
Scott Kellogg
Peoria, Il3gmail.com, gmail.com, cat.com2 +121751XXXXX
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial